In Vivo is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

Abbott Diabetes Care Inc.

www.abbottdiabetescare.com

Latest From Abbott Diabetes Care Inc.

How Viable Is The Future Of The “Traditional” CGM?

Flagship products like Dexcom’s G7 and Abbott’s FreeStyle Libre 3 offer currently unrivalled accuracy of blood glucose measurement. However, as truly noninvasive technologies improve, the future basis for these companies’ growth is on shaky ground.

New Science Diabetic Care

FDA Clears Abbott’s Libre 3

Abbott’s FreeStyle Libre 3 system will soon be available in the US. It is 70% smaller than the Libre 2 while also providing better accuracy.

Diabetic Care Approvals

ATTD 2022: Mic Drop Moment As Medtronic Presents 780G Data Proving Closed Loop Ability

Results of the ADAPT study presented at the Advanced Technologies & Treatments for Diabetes conference in Barcelona support Medtronic’s hope that the 780g insulin pump will help to turn around its diabetes business or make it an attractive acquisition for another company.

Diabetic Care Clinical Trials

Dexcom Shows Off More G7 Data

The newly published data solidifies the G7 as an improvement over the G6 and supports its potential as a 14-day wearable.

Diabetic Care Clinical Trials
See All

Company Information

  • Industry
  • Medical Devices
    • Monitoring Equipment & Devices
  • In Vitro Diagnostics
    • Biosensors
    • Glucose Testing
UsernamePublicRestriction

Register